Armstrong Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History

Armstrong Advisory Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$504K	Sell	1,005 -2	-0.2%	-$960	0.03%	146
2026 Q1	$495K	Sell	1,007 -34	-3%	-$18.5K	0.03%	140
2025 Q4	$603K	Buy	1,041 +2	+0.2%	+$1.13K	0.04%	124
2025 Q3	$504K	Buy	1,039 +23	+2%	+$10.7K	0.04%	132
2025 Q2	$412K	Hold	1,016	–	–	0.03%	139
2025 Q1	$529K	Hold	1,016	–	–	0.04%	108
2024 Q4	$529K	Sell	1,016 -22	-2%	-$12.1K	0.04%	108
2024 Q3	$642K	Sell	1,038 -9	-0.9%	-$5.33K	0.05%	90
2024 Q2	$579K	Buy	1,047 +9	+0.9%	+$5.16K	0.05%	90
2024 Q1	$551K	Hold	1,038	–	–	0.05%	89
2023 Q4	$551K	Hold	1,038	–	–	0.05%	89
2023 Q3	$525K	Buy	1,038 +19	+2%	+$10.1K	0.06%	80
2023 Q2	$532K	Sell	1,019 -68	-6%	-$36.7K	0.06%	85
2023 Q1	$627K	Hold	1,087	–	–	0.07%	76
2022 Q4	$599K	Buy	+1,087	New	+$576K	0.08%	80

Other funds holding TMO

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Armstrong Advisory Group's TMO Position: Q2 2026 in Review

Armstrong Advisory Group reduced its Thermo Fisher Scientific (TMO) stake by 0.2% in Q2 2026, selling an estimated $960 and leaving 1,005 shares worth $504K. The position accounts for 0.03% of the portfolio, ranked #146.

Armstrong Advisory Group first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $642K in Q3 2024. 429 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Armstrong Advisory Group held 1,005 shares of Thermo Fisher Scientific worth $504K as of Q2 2026.
Armstrong Advisory Group sold 2 Thermo Fisher Scientific shares in Q2 2026, an estimated $960.
Thermo Fisher Scientific made up 0.03% of Armstrong Advisory Group's portfolio in Q2 2026, its #146 holding.
Armstrong Advisory Group first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
Armstrong Advisory Group's Thermo Fisher Scientific position peaked at $642K in Q3 2024.
429 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.